Weighing it honestly
Is rehab worth it? The honest UK answer depends less on the rehab and more on what happens after. What the research says, who benefits, and what actually predicts success.
Short, honest answer: it depends, and it depends far less on which rehab than on what happens for the twelve months after discharge. Decades of UK and international trials (UKATT, Project MATCH, COMBINE, the UK NDTMS cohort) consistently find that no one treatment modality dramatically outperforms the others once engagement is matched, and that sustained contact with support in the first year is the single biggest outcome lever anyone has measured.
The implication is not that rehab is pointless. For some people in some situations it is the right move, and sometimes the only safe one. It is that spending £8,000 to £20,000 on a residential month without a serious aftercare plan is like paying for a plane ticket and forgetting the hotel. The month inside is the start of the work, not the whole of it.
12stepfinder has no clinic relationships, no affiliate links, and no financial interest in whether you pick rehab or something else. This page lays out the research, the people it tends to help most, the people who often do as well on cheaper routes, and what any route needs to include to work. Related pages: Do I need rehab?, I need rehab: four honest UK routes, Alternatives to rehab in the UK.
Last updated: 10 November 2026.
A typical private rehab stay in the UK is 28 days. The first 7 to 10 days are a medically supervised detox (relevant for alcohol, benzodiazepines and opioids; stimulants and cannabis do not need one). The rest is a mix of group therapy, one-to-one counselling, structured education sessions, and shared living. Most UK centres run on a twelve-step framework; a smaller number use cognitive-behavioural, trauma-focused, or integrative models. A few offer dual-diagnosis care for people with a co-occurring mental health condition.
The main ingredient residential provides that community treatment cannot is isolation from the home environment. For someone whose drinking or using is tangled with a partner who also drinks, a flat full of paraphernalia, or a job that revolves around after-work rounds, that separation can be the difference between a reduction plan that holds and one that collapses on day two.
The costs sit on a wide range. At the lower end, charity-run or Christian recovery houses can be £3,000 to £6,000 for a full stay, sometimes less or free with means-testing. Mid-market private centres are typically £5,000 to £15,000. The more marketed premium end runs £15,000 to £25,000 and occasionally higher. NHS-funded residential treatment exists but is rare; your community alcohol or drug service holds the local funding panel and the bar is high.
The single most important UK trial on alcohol treatment is UKATT (the UK Alcohol Treatment Trial), published in the BMJ in 2005 and still the reference study here. It compared two outpatient approaches (motivational enhancement therapy and social behaviour and network therapy) across 742 clients in seven centres. At twelve months the two groups were statistically indistinguishable on drinking outcomes and on cost-effectiveness. Both worked. Neither was clearly better.
Project MATCH in the US, with over 1,700 participants, reached the same conclusion across three different modalities. The much larger COMBINE study, which added relapse-prevention medication to the mix, found that medical management plus medication was as good as more intensive specialised therapy for most patients. The most honest reading of the full body of trials is that for the majority of people, what matters more than which door they go through is that they keep going through doors.
The UK National Drug Treatment Monitoring System, now held by OHID and published annually on ndtms.net, tracks outcomes across the whole adult treatment population. Successful completion rates vary by substance and by service type, but across the board the strongest predictor of good outcomes is sustained engagement past the first 90 days, not whether that engagement was residential or community-based.
This is not a league table. The two columns sit at opposite ends of a trade-off, and the real question is which one fits a given life. For most UK readers, intensive community treatment via a GP and a commissioned service is both available and affordable; residential rehab is the option when something about home makes staying there incompatible with stopping.
| Dimension | Private residential rehab | Intensive community treatment |
|---|---|---|
| Typical UK cost | £5,000 to £25,000 (self-paid) | Free (NHS-commissioned) |
| Length | 28 days most commonly, some 60 or 90 day options | Open-ended; typical active phase 3 to 6 months |
| Detox included | Yes, medically supervised | Yes for most clients, home-based with nurse visits |
| Therapy hours per week | 20 to 30 hours of structured groups and one-to-one | 2 to 6 hours of groups and keyworker time |
| Separation from home triggers | Full for 28 days | None; you stay in your life |
| Aftercare included by default | Varies; some centres include 6 to 12 months, many do not | Aftercare is the service |
| Risk of relapse in month 1 without aftercare | High, around 40 to 60 percent across UK and international follow-up studies | Lower, because the service continues |
| Access time from first phone call | Days to weeks for self-pay; many months for rare NHS funding | Days to a few weeks in most English and Scottish areas |
| Works if you cannot take 4 weeks off work | No | Yes |
Severe physical dependence combined with an unstable or unsafe home environment is the clearest fit. Someone drinking a bottle of spirits a day, sharing a flat with others who are also drinking, with no one to call at 3am, is in a situation that a community detox cannot safely hold, and the structure of residential care genuinely changes what is possible.
A pattern of repeated short attempts at stopping in a chaotic environment is another one. If three home detoxes in the past year have each lasted four days, the problem is not willpower; it is that nothing about the environment changed. A reset in a new setting can break that loop in a way more of the same cannot.
Co-occurring mental health conditions where outpatient services are not holding the risk is a third. A few UK centres (not all) are set up to treat depression, PTSD, personality disorders and eating patterns alongside the substance use. If this is you or someone you love, ask directly about dual-diagnosis provision and about the specific qualifications of the clinical team, not just about the rooms.
Being able to take 28 days away from work and family without losing either is the quiet precondition most marketing does not mention. For self-employed people, primary carers, or anyone on precarious contracts, that absence can itself cost more than the fees.
Moderate dependence, stable housing, a supportive partner or family, work that is willing to flex, and no severe co-occurring conditions: this profile frequently does as well with a GP-led home detox, a community alcohol or drug service, and either AA or SMART Recovery alongside, as it would in a £15,000 residential month. The research is consistent on this. The marketing is not.
People in the early-contemplation stage of change, where readiness is not yet solid. Sending someone to residential before they are ready can produce a technically successful 28 days followed by a drink in the taxi home. Short-of-residential routes (a few weeks of community contact, a few AA or SMART meetings, a GP conversation) often do more to shift readiness than a dramatic intervention can.
People whose main need is community and structure rather than detox. Peer support is unusually good at this. AA and SMART Recovery between them offer multiple meetings every day of the week across the UK, free, with no admissions process; the online cluster adds hundreds more from anywhere with a phone.
Across UK and international follow-up studies, between 40 and 60 percent of people who complete residential rehab return to some level of use within 90 days of discharge unless structured aftercare is in place. That figure is not a judgement on rehab; it is a judgement on what tends to happen when someone is dropped back into the environment that produced the problem, with a certificate and a leaflet.
What breaks the pattern is not willpower; it is structure. Meetings in the diary before discharge, a sponsor or peer contact assigned, an appointment with the community service within the first week out, a therapist arranged, relapse-prevention medication prescribed where indicated, and a frank conversation with family about what happens on the first difficult evening. UK charities including Adfam run free resources for the family half of that conversation.
A pound spent on three months of structured aftercare, in most follow-up data, moves outcomes more than an extra fortnight of residential. If a rehab's aftercare plan is a single sheet of printed phone numbers, that is the signal, not the rooms or the sea view.
Attendance at peer support in the first year, counted in meetings per month rather than membership on paper. Multiple UK and US studies (including long-running follow-up on AA members by Project MATCH and more recent SMART Recovery UK outcomes) show a dose-response relationship: more contact, better outcomes, up to a plateau around two meetings a week.
Adherence to any prescribed relapse-prevention medication. For alcohol, acamprosate, naltrexone and disulfiram are the three NICE-recognised options; for opioids, methadone or buprenorphine; for stimulants, no approved pharmacotherapy exists but medication for co-occurring anxiety or depression often helps indirectly. All of these are free on the NHS.
Housing stability. People without stable housing have worse outcomes regardless of what else is in place; this is one of the most consistent findings in the NDTMS data, and it is why your community service's care plan starts here rather than at the group room.
Employment or structured day-time activity. Not necessarily a full-time job; study, volunteering, caring for someone, or a structured recovery programme all count. The specific thing that matters is that waking up has a shape.
Therapeutic alliance. Across every modality studied, the single strongest predictor of outcome for people in any form of talking therapy is whether the client feels understood and respected by the person opposite them. A poor fit with a £15,000 rehab clinician is worse than a good fit with a free SMART Recovery facilitator. Ask about the team before you ask about the building.
Ask for their published outcome data. Not glossy testimonials, numbers: what percentage of people completing their programme are abstinent, or significantly reduced, at 6 and 12 months, and how did they measure it. Centres that have these numbers to hand tend to be the ones doing the work; centres that answer the question with marketing should be treated accordingly.
Ask who is clinically responsible, by name and qualification. A medical director registered with the GMC. A lead therapist registered with BACP, UKCP, BABCP or the BPS. Dual-diagnosis provision led by a consultant psychiatrist, if that applies. CQC registration for English providers and the equivalent in Scotland, Wales and Northern Ireland.
Ask about aftercare in writing: how many weeks or months, how often, free or paid, in person or remote, with whom. A programme that cannot answer this on the phone has not thought about the single biggest outcome lever.
Ask what happens if a client relapses during the programme. A programme whose honest answer is some version of we work with them in place is doing recovery; a programme whose answer is some version of we discharge them is doing something else.
Charity and faith-based recovery houses run roughly £3,000 to £6,000 for a full stay, sometimes less or free with means-testing. Mid-market private centres are typically £5,000 to £15,000 for a 28-day stay. The marketed premium end runs £15,000 to £25,000 and occasionally higher. Aftercare, if included, is a different line and worth asking about explicitly.
There is no single honest figure. Published UK and international follow-up studies show roughly 40 to 60 percent of people complete residential and return to some level of use within 90 days of discharge without structured aftercare in place, and that figure improves considerably with twelve months of continuing support. Any centre quoting a flat high success rate without defining what they measured and over what period should be asked to show the data.
Rarely and selectively. NHS-funded residential treatment exists and is decided by local funding panels run via your community drug or alcohol service. The bar is high, usually requiring a documented history of failed community treatments and a clinical case for residential. In most English, Scottish, Welsh and Northern Irish areas, the usual NHS route is community-based detox and ongoing keyworker support rather than residential.
There is no published evidence that the clinical outcomes of premium rehabs are better than those of mid-market or charity centres. The research on what actually works, from UKATT onwards, points to therapist skill, programme content and aftercare rather than building quality. A good clinical team in a plain room will outperform an average team in a luxurious one. Ask about the staff and the aftercare first.
Detox stops the body being physically dependent. It does not change anything about why the drinking or using started. The published follow-up on detox-only treatment is poor: without anything that addresses the behavioural and environmental side, return to use is typical within weeks. This is why most reputable UK centres will not accept detox-only self-referrals, and why the community services pair detox with keyworker support and peer options as standard.
Published outcome data at 6 and 12 months. Named clinical leadership with checkable registrations (GMC, BACP, UKCP, BABCP, BPS, CQC). A written aftercare plan that lasts longer than discharge day. A clear policy on in-programme relapse that keeps the person in treatment. Transparent pricing with aftercare costs itemised separately. Reluctance to answer any of these questions is itself an answer.